Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Struewing

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
American Journal of Human Genetics|July 1, 1995
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancerJ P Struewing, L C Brody, M R Erdos, et al.
Nature Genetics|September 10, 1998
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi JewsT Woodage, S M King, S Wacholder, et al.
The Journal of Infectious Diseases|August 1, 1992
Efficacy of hepatitis B vaccination in primary school children from a village endemic for Schistosoma mansoniS Bassily, G T Strickland, M F Abdel-Wahab, et al.
Genes, Chromosomes & Cancer|May 1, 1994
Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cMS A Smith, R A DiCioccio, J P Struewing, et al.
Nature Genetics|September 1, 1994
Germline p16 mutations in familial melanomaC J Hussussian, J P Struewing, A M Goldstein, et al.
American Journal of Human Genetics|June 28, 2000
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone familiesP Ciotti, J P Struewing, M Mantelli, et al.
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
The New England Journal of Medicine|October 12, 1995
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutationsA M Goldstein, M C Fraser, J P Struewing, et al.
Gynecologic Oncology|September 28, 2000
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations statusA Fishman, E Dekel, A Chetrit, et al.
Nature Genetics|October 1, 1996
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%C Oddoux, J P Struewing, C M Clayton, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
American Journal of Human Genetics|July 1, 1995
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancerJ P Struewing, L C Brody, M R Erdos, et al.
Nature Genetics|September 10, 1998
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi JewsT Woodage, S M King, S Wacholder, et al.
The Journal of Infectious Diseases|August 1, 1992
Efficacy of hepatitis B vaccination in primary school children from a village endemic for Schistosoma mansoniS Bassily, G T Strickland, M F Abdel-Wahab, et al.
Genes, Chromosomes & Cancer|May 1, 1994
Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of < or = 1 cMS A Smith, R A DiCioccio, J P Struewing, et al.
Nature Genetics|September 1, 1994
Germline p16 mutations in familial melanomaC J Hussussian, J P Struewing, A M Goldstein, et al.
American Journal of Human Genetics|June 28, 2000
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone familiesP Ciotti, J P Struewing, M Mantelli, et al.
The New England Journal of Medicine|July 28, 2001
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutationB Modan, P Hartge, G Hirsh-Yechezkel, et al.
The New England Journal of Medicine|October 12, 1995
Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutationsA M Goldstein, M C Fraser, J P Struewing, et al.
Gynecologic Oncology|September 28, 2000
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations statusA Fishman, E Dekel, A Chetrit, et al.
Nature Genetics|October 1, 1996
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%C Oddoux, J P Struewing, C M Clayton, et al.
Pageof 5